Mesoblast | MSB - Capital Social Ordinario





Capital Social Ordinario Cambio Fecha
Clinuvel Pharmaceuticals AUD 50.2M 77.11K 2025-12
Cochlear AUD 65.4M 1.12B 2025-12
CSL USD 482.13M 93.87M 2025-12
Pacific Edge NZD 1.02B 497K 2026-06
Paradigm Biopharmaceuticals AUD 428.52M 39.09M 2025-12
PYC Therapeutics AUD 597.24M 366.66M 2025-12
Ramsay Health Care AUD 229.93M 29.81K 2025-12
Sonic Healthcare AUD 4.15B 467K 2024-12
Starpharma Holdings AUD 419.92M 179.17M 2025-12
Telix Pharmaceuticals AUD 338.78M 379K 2025-12